Defense awards $67M for airworthy defibrillators

Candace Stuart | | Cardiovascular Business | Heart Rhythm

The Department of Defense awarded contracts topping a combined $67 million to two companies for airworthy defibrillators under its war-stopper funds.

Zoll Medical will receive $39.8 million under a five-year contract. Zoll manufactures the Propaq MD, an airworthy defibrillator that allows for monitoring patients during long transports. The device has been cleared by the FDA and includes a night vision mode.

Philips Healthcare’s $27.4 million, five-year contract also is for airworthy defibrillators. Philips makes the HeartStart MRx Monitor/Defibrillator, which has been certified by the U.S. Army as airworthy and received a Safe-to-Fly certificate from the Air Force. It combines defibrillation and monitoring technology.

Zoll Medical in Chelmsford, Mass., and Philips Healthcare is in Andover, Mass.

 

Candace Stuart, Contributor

Related Content

FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths
Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker
President of medical device company resigns over conduct allegations after 7 months in role
FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths
Treating AFib patients with TAVR still linked to elevated risks
Cardiologists work to standardize the diagnosis and management of acute myocarditis

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.